Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

WHAT'S NEW

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 21 2022

Full Issue

Viewpoints: Comprehensive Sex Ed Is More Important Than Ever; Public Funding Essential In Pro-Choice States

Editorial writers delve in to abortion and other public health topics.

The New York Times: After Roe, Sex Ed Is Even More Vital 

High quality, evidence-informed sex education is critically important, effective and supported by an overwhelming majority of Americans. Limiting access to that instruction threatens the health and safety of young people, particularly those in states where access to reproductive health care is scarce in post-Roe v. Wade America. (Eva Goldfarb and Lisa Lieberman, 7/20)

The Colorado Sun: Change The Colorado Constitution To Allow Public Abortion Funding

Colorado is not prepared for the imminent surge in demand for abortions. Following the Supreme Court decision overturning Roe vs. Wade, our state is now a pro-choice island, so we must take steps to ensure wide and equitable access to abortion. (Logan Harper, M.D., 7/21)

Scientific American: Police Who Tear Gas Abortion-Rights Protesters Could Induce Abortion 

After the recent ruling by the Supreme Court overturning federal abortion rights, people have taken to the streets in protest. In multiple places, police attacked protesters with chemical weapons in the form of tear gas. In Arizona, law enforcement even fired canisters from the windows of government buildings. (Matthew R. Francis, 7/20)

Also —

Houston Chronicle: It’s A Myth That Sunscreen Prevents Melanoma In People Of Color — A Dermatologist Explains

Melanoma is a potentially deadly form of skin cancer that effects people of every racial and ethnic group. The risk factor most closely linked to developing melanoma is exposure to ultraviolet, or UV, rays from the sun. In fact, sunburns have been associated with doubling one’s risk of melanoma. (Adewole S. Adamson, 7/20)

Dallas Morning News: Congress Should Take Action Against Nonmedical Switching

Americans face a growing mental health crisis, made worse by a health insurance practice called nonmedical switching. Congress can make this right. They should take action now. (Greg Hansch, 7/21)

Stat: 10 Tips For Vendors Aiming To Market Digital Health Solutions

Virtual and digital care expanded dramatically during the pandemic as patients, providers, employers, and regulators sought to limit the risk of contracting Covid-19 during hospital and medical visits. Even so, digital health care and virtual health still account for under 2% of all medical expenses, so there is plenty of opportunity for growth. (Jeff Levin-Scherz and Andrey Ostrovsky, 7/20)

Stat: 6 Ways To Increase Diversity In Clinical Trial Participation 

It has been nearly 25 years since the Food and Drug Administration first issued guidance related to racial, ethnic, age, and gender populations underrepresented in clinical trials (see “Timeline: Related prior FDA guidance”). Yet it and other agency guidance and clear documentation of unequal representation have yielded little progress in improving clinical trial diversity. (Nicholas Kenny, Keri McDonough and Stephen Keith, 7/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF